🔴 Cue Biopharma is trading 7% down today with no clear company-specific catalyst

Cue Biopharma is trading 7.24% down now at $26.38 after no clear company-specific catalyst was identified for September 2, 2026.

• The latest company release, dated August 3, concerns a CFO appointment and CUE-221 regulatory filing.
• No September 2 announcement appears in the company’s release feed; biotech is up 2.75%.
• The move remains unexplained and warrants re-checking for delayed news.